First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.
Saved in:
| Title: | First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France. |
|---|---|
| Authors: | Dourthe LM; Clinique Sainte-Anne, Strasbourg, France., Guillot A; Hôpital Privé de la Loire, Saint-Étienne, France., Vassal C; Hôpital Privé de la Loire, Saint-Étienne, France., Kazan E; Hôpital Privé La Louvière, Lille, France., Coeffic D; Hôpital Privé de Provence, Aix-en-Provence, France., Rebischung C; Médipôle de Savoie, Challes-les-Eaux, France., Suau D; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Lahouegue A; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Aboulabbes S; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France., Falabrègues A; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France. amelie.falabregues@astrazeneca.com., Ould Lahsen H; AstraZeneca, 31 Place des Corolles, 92400, Courbevoie, France. |
| Source: | Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 211-224. Date of Electronic Publication: 2026 Apr 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
